Morgan Stanley downgraded Globus Medical (NYSE: GMED) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.

Shares of Globus Medical closed at $26.43 yesterday.

Downgrades

UPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to HoldJuly 27, 2016 7:17 AM Wells Fargo Upgrades Globus Medical (GMED) to Market PerformJuly 27, 2016 7:16 AM Leerink Partners Downgrades Globus Medical (GMED) to Market PerformJuly 27, 2016 7:12 AM Globus Medical (GMED) Reports In-Line Q2 EPSJuly 26, 2016 4:41 PM Globus Medical (GMED) to Acquire Alphatec International Business in $80M DealJuly 26, 2016 4:39 PM